[炎症性细胞因子水平与长期婴儿的生长限制之间的相关性]
Yaling Jin1, Xiaocui Ren1, Bao Geng1
1() ( 054000) Department of Child Health, Xingtai Central Hospital (Affiliated Hospital of Xingtai Medical College), Xingtai 054000, China.
概括
增加的孕产妇和新生儿炎症标志物,如瘤坏死因子-α (TNF-α),干白素-6 (IL-6) 和C反应蛋白 (CRP),与早产婴儿有关. 然而,这些指标并不能预测六个月后的追赶增长.
科学领域:
- 生物医学科学 生物医学科学
- 新生儿研究新生儿研究
- 炎症标记物 炎症标记物
背景情况:
- 过小的婴儿面临着不良健康结果的风险增加.
- 炎症性细胞因子,包括TNF-α,IL-6和CRP,在胎儿发育和生长中发挥作用.
- 这些炎症标志物与长期婴儿的生长限制之间的关联需要进一步调查.
研究的目的:
- 为了检查TNF-α,IL-6和CRP的血清水平之间的相关性,在满期的婴儿和他们的母亲中.
- 评估这些炎症标志物的预测价值,以确定幼儿的发病率.
- 为了确定这些标志物是否与六个月大时的追赶增长相关.
主要方法:
- 一项病例对照研究,涉及83名满期小早产婴儿和72名健康对照.
- 测量TNF-α,IL-6和CRP的母体和新生儿血清水平.
- 后勤回归和ROC曲线分析以确定影响因素并评估预测值.
主要成果:
- 与对照组相比,在小前期婴儿组中观察到TNF-α,IL-6和CRP的母体和新生儿血清水平升高 (P < 0.001).
- 孕产妇的BMI和TNF-α,IL-6和CRP的血清水平与过小婴儿的发病率有显著的相关性.
- 只有出生体重,而不是炎症标志物,显著预测了六个月的追赶增长.
结论:
- 孕产妇的BMI和TNF-α,IL-6和CRP的孕产妇/新生儿血清水平与期满的早产婴儿的生长限制有关.
- 母体血清中TNF-α,IL-6和CRP的水平显示出预测过小婴儿发生的潜力.
- 这些炎症标志物的新生儿血清水平在出生时与六个月的令人满意的追赶增长没有相关性.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...


